Salud
A new drug could change the fate of ALS patients in Madrid
An innovative drug called AP-2 begins clinical trials in Madrid, offering new hope to patients with amyotrophic lateral sclerosis.
ELA
Latest ELA news
5 articles
Salud
The Community of Madrid launches innovative technological initiatives for ALS patients
The Community of Madrid presents new technologies to improve the lives of ALS patients at an innovative meeting.
Salud
The voice that never fades: the innovative voice bank at Zendal for ALS patients
The Hospital Enfermera Isabel Zendal launches an innovative voice bank to preserve the vocal identity of ALS patients.
Salud
Madrid revolutionises ALS rehabilitation with pioneering robotic exoskeleton
The Enfermera Isabel Zendal Hospital introduces a unique robotic exoskeleton to improve the quality of life and treatment for ALS patients.
Salud
Madrid pioneers the fight against ALS with an innovative clinical trial
Madrid launches an innovative clinical trial with the drug AP-2 to treat Amyotrophic Lateral Sclerosis (ALS), marking a milestone in medical research.